title: Preventing Central Line-Associated Bloodstream Infection: In Reply to Mermel.
authors.affiliation: St Louis, MO.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Bonne
authors.affiliation: St Louis, MO.
authors.forename: John E
authors.initials: JE
authors.lastname: Mazuski
authors.affiliation: St Louis, MO.
authors.forename: Douglas J E
authors.initials: DJ
authors.lastname: Schuerer
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage*; D016470:Bacteremia / Q000517:prevention & control*; D055499:Catheter-Related Infections / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008911:Minocycline / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage*
chemical_list: D000890:Anti-Infective Agents; D008911:Minocycline; D012293:Rifampin